# Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence

> **NCT00385801** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 31 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00385801
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385801, "Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00385801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*